Ultrasound assisted particle and cell manipulation on-chip by Mulvana, Helen et al.
 Page 1 of 22 
 
Ultrasound assisted particle and cell 
manipulation on-chip 
Helen Mulvana
a
, Sandy Cochran
b
 and Martyn Hill
c* 
a School of Engineering, University of Glasgow, Glasgow G12 8QQ, United Kingdom 
b Institute for Medical Science and Technology, University of Dundee, DD2 1FD Dundee, United Kingdom 
c Engineering Sciences and Institute for Life Sciences, University of Southampton, Southampton, United 
Kingdom 
*
 Corresponding author: Engineering Sciences, University of Southampton, Southampton, United Kingdom. Tel 
+44 23 8059 3075.  E-mail address m.hill@soton.ac.uk 
 
ABSTRACT 
Ultrasonic fields are able to exert forces on cells and other micron-scale particles, including microbubbles.  The 
technology is compatible with existing lab-on-chip techniques and is complementary to many alternative 
manipulation approaches due to its ability to handle many cells simultaneously over extended length scales.  
This paper provides an overview of the physical principles underlying ultrasonic manipulation, discusses the 
biological effects relevant to its use with cells, and describes emerging applications that are of interest in the 
field of drug development and delivery on-chip. 
1. INTRODUCTION 
Ultrasound is well known as a diagnostic imaging technique. However, its basis in pressure waves also allows it 
to be used to realise physical processes. In these, the role of the ultrasound is usually to transfer energy from a 
convenient location for its generation, through transduction of electrical to mechanical energy by piezoelectric 
material, to a location where it is applied. For example, ultrasound may be applied to the surface of the human 
body for non-invasive hyperthermic surgery [1], or it may be applied at a remote location in a lab-on-chip 
system to control or sort particles within a microfluidic channel [2]. 
Whilst ultrasound is sometimes utilised directly, e.g. to move small objects around through radiation force, a 
secondary transduction process is often utilised at the application location, e.g. through generation of 
cavitation bubbles [3] or heat, or through resonance of microbubbles to transform the energy in the wave into 
highly directed or otherwise localised fluid flow [4].  Approaches using microbubbles are discussed throughout 
the paper and covered in detail in section 4.3. This secondary transduction process provides a great deal of 
flexibility in its application and thus a very wide range of possible schemes and devices. 
1.1 Why is it relevant?  
Ultrasound has two separate domains of application relating to drug delivery. The first is as one of several 
techniques to manipulate cells and particles, including vehicles such as microbubbles for tasks such as drug 
discovery and delivery in microfluidic lab-on-chip devices [5], and the second is to mediate drug delivery in 
vivo, e.g. by applying local forces to tissues, which can enhance porosity, or to the drug delivery vehicles [6]. In 
both domains, ultrasound may also assist with the release of drugs from specific vehicles [7, 8]. As ultrasound 
has applications in both the laboratory and in vivo domains it has added-value for translation from the 
laboratory, the focus of this paper, to the clinical application. 
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When considering microfluidic platforms, ultrasound can trap, levitate, and manipulate cells, large liposomes, 
and bubbles within a controlled environment.  Further, ultrasonic fields can be used to construct cell 
aggregates and to increase mass transfer within the microfluidic environment. Thus ultrasound offers multiple 
opportunities to enhance on-chip functionality. In Section 2 we summarise the physical acoustic principles 
which may be harnessed within on-chip devices, while in Section 3 some key biological effects relevant to 
ultrasonic manipulation in vitro, including the potential to enhance or initiate drug delivery, are discussed. 
Several groups have demonstrated the capability of these techniques on-chip and such devices are discussed 
in Section 4 with particular emphasis on their applications in tissue engineering (4.2), and the study of drug-cell 
interactions for drug development and delivery (4.3).  
 
2. PHYSICAL PRINCIPLES 
 
Ultrasonic excitation within microfluidic systems typically leads to complex fields characterised by acoustic 
energy gradients of various length scales.  These energy gradients underlie two phenomena of significance for 
the manipulation of cells and drug delivery vehicles such as microbubbles on chip: acoustic radiation forces 
and acoustic streaming.  These are described in the following subsections prior to a discussion of the devices 
and typical parameters used in microfluidic ultrasonic manipulation. 
 
 
 2.1 Radiation forces  
Cells within an ultrasonic field experience high frequency oscillatory forces due to the linear component of the 
acoustic field, but these forces have time-averages of zero that do not lead to translation of the cells.  However 
there are second order terms within the field which have a finite time-average and generate acoustic radiation 
forces that can be used for steady state manipulation and levitation of cells and other particles.  King [9] 
derived an expression for the acoustic radiation forces on a spherical, rigid particle in an in inviscid fluid and 
this analysis was extended by Yosioka and Kawasima [10] to allow for compressible particles and bubbles.  
Recently Bruus [11], following the approach of Gor’kov [12], developed a simple expression to allow for 
viscous effects.  For the inviscid case [11] the radiation force acF  on a spherical particle of volume V which is 
small in relation to the wavelength of a standing wave is: 
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The time averages (represented by  ) of the squares of the acoustic pressure p  and velocity v  are 
proportional to the potential and kinetic energy densities of the standing wave field and it is the gradients of 
these energies that interact with the compressibilities ( 0 , p ) and densities ( 0 , p ) of the fluid and 
particle respectively.  The coefficients 1f  and 2f  are given by  
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It can be seen that the gradient of the potential energy density interacts with the compressibilities of the 
particle and fluid to produce one component of the radiation force, while the gradient of the kinetic energy 
density interacts with the density difference between the particle and fluid to produce the other component of 
the force. Typically, the near-neutral buoyancy of cells and of some drug delivery vehicles means that the force 
is dominated by the pressure-compressibility interaction.  Bruus [11] also demonstrated that the effect of 
 Page 3 of 22 
 
viscosity on the radiation force can be represented by a correction to the coefficient 
2f  and showed that the 
influence of viscosity is small if the density difference between the particle and fluid is small.   
Depending on the geometry of the acoustic field these forces can be used to levitate cells and move them 
away from a surface, to trap cells against a flow [13], to push cells against a surface [14] or to bring cells 
together in a prescribed geometry [15].  The agglomeration of cells is modified by the existence of secondary 
radiation forces [16] in which the scattered field from one cell exerts a force on an adjacent cell.  Such forces 
are only significant over short distances and generally act to draw cells together once they are in close 
proximity. 
The coefficients 1f  and 2f  can each be either positive or negative depending on the relative compressibility 
and density respectively of the fluid and the particle.  For particles such as cells and loaded liposomes which 
are slightly denser and less compressible than an aqueous medium, both coefficients are positive, tending to 
move cells to areas of low acoustic pressure amplitude (pressure nodes) and high acoustic velocity amplitude.  
However, less dense, more compressible particles will move to regions of high acoustic pressure amplitude 
and low acoustic velocity amplitude.  This is the case for small bubbles, i.e. those that are driven at a frequency 
below their own acoustic resonance frequency.  However larger bubbles, driven at a frequency that is higher 
than their resonance, will be forced towards a pressure node [10], as their scattered field changes phase above 
resonance.  The acoustic radiation force on bubbles has been used to align, trap, and transport bubbles in 
micro-channels [17, 18], and to move bubbles to a target surface [19]. 
 
 2.2 Acoustic Streaming  
Gradients of acoustic energy density also lead to acoustic streaming: the acoustic generation of net fluid flows 
[20].  The two main sources of streaming are: i) due to acoustic energy dissipation into the bulk of a fluid, and 
ii) due to energy dissipation from the interaction of an acoustic field with a boundary.  The first of these 
mechanisms, also known as “Eckart streaming”, or the “quartz wind”, is caused by attenuative loss over a 
number of wavelengths so is typically only an issue in microfluidic devices when high frequency waves 
propagate along the length of a channel [21].  It is also less likely to be observed in standing wave systems in 
which the forces leading to Eckart streaming from counter-propagating waves tend to cancel each other out.  
The second mechanism occurs due to steep energy gradients within the acoustic boundary layer adjacent to a 
wall (“boundary layer driven” streaming) or near the surface of an oscillating bubble (“cavitation 
microstreaming”), and these forms of streaming are widely observed in ultrasonically excited microfluidic 
devices. 
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Figure 1. Schematic representation of streaming between two rigid walls (top and bottom) generated within an acoustic 
standing wave running left to right between two rigid reflectors, based on a figure included in [22]. 
 
Boundary layer driven streaming was first analysed by Rayleigh [23], describing the flow observed within a 
standing wave between parallel walls that leads to the four vortices within each half wavelength that 
characterises Rayleigh streaming (see Figure 1). Each of these four outer vortices is driven by an inner vortex 
generated by viscous losses within the viscous boundary layer.  For a standing wave in water with a frequency 
in the low MHz range the wavelength will be of the order of 1 mm, while the viscous boundary layer depth will 
be of the order of 1 µm [21].  Hamilton et al. [22] show that for very narrow channels, Rayleigh’s analysis 
ceases to be valid, and ultimately the outer streaming vortices cease to exist.  More recently, Lei et al. [24] 
have shown that boundary driven streaming in microfluidic devices can occur in planes orthogonal to classical 
Rayleigh vortices. 
Streaming can disrupt the ordered manipulation of cells via acoustic radiation forces as particles are drawn 
along the streaming vortices by the viscous drag forces.  On large particles the radiation forces tend to 
dominate, while smaller particles are influenced primarily by the streaming drag.  Bruus [25] has shown that 
for typical particles in a 1 MHz standing wave in water the critical diameter below which streaming drag 
dominates is of the order of 2 µm.  In other cases, the existence of streaming can be used to positive effect, 
improving mixing and mass transfer in biosensing applications [26], enhancing the interaction of cells and 
retroviruses [27], agglomerating cells in droplets [28] and the removal of non-specifically bound proteins from 
surfaces [29]. 
 
 
 2.3 Devices for on-chip ultrasonic manipulation 
A variety of different types of device have been used for ultrasonic manipulation [30].  Probably the simplest 
approach is to use a layered, or planar, resonator [31] comprising a transducer, which is typically isolated from 
the fluid in which the cells are suspended by a carrier, or coupling layer.  The standing wave is maintained by a 
passive reflecting layer at the far side of the fluid, as shown in Figure 2. 
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  (a)    (b)     (c) 
Figure 2. Schematic representation of layered resonator.  A standing wave is set up by exciting the transducer at a 
resonant frequency which generates a pattern of pressure gradients within the fluid which effect the cell manipulation.  
Uniformly distributed cells (a), first move to a pressure node (b) and are then brought together within the node (c). 
 
Such a resonator may be many wavelengths across, resulting in multiple planes into which cells are gathered 
[32].  Generally, the fluid layers in the microdevices considered here will be less than a wavelength thick and 
will gather cells into a single nodal plane [33, 34].  An alternative arrangement, the transversal resonator, has 
been used extensively by Laurell’s group in Lund [30, 35].  In this arrangement the standing wave is established 
parallel to the transducer face such that manipulation operations can be easily observed through a glass cap 
above the channel and also parallel to the transducer face.  Variations on these approaches can use glass 
capillaries [36] or a combination of planar and transversal excitation [37].   
A rather different approach to the excitation of the ultrasonic field uses surface acoustic waves (SAWs) 
coupled into a micro-channel [38, 39].  The SAWs are generated using interdigitated electrodes printed onto a 
piezoelectric substrate – typically lithium niobate – and generally the channel is fabricated from PDMS which is 
bonded on to the substrate.  The use of transducer pairs allows a standing SAW to be established [40] which 
can be used to pattern particles or cells in one or two dimensions [41].  Using SAWs, significantly higher 
frequencies can be achieved (up to 150 MHz) allowing resolutions which can easily approach the single cell 
level, particularly when combined with focusing, which is typically achieved using phononic crystals [42].  
SAWs can also be used to initiate fluid flow [39] and to provide energy (thermal and mechanical) for micro cell 
processing including PCR and cell lysis. A useful review of recent advances in SAW devices is presented by 
Wang et al. [43].  
Recently there has been substantial interest in building devices that allow more dexterous manipulation of 
particles through the use of planar arrays of transducers [44] and different configurations of opposing 
transducers [45, 46].  
 
 2.4 Limitations and typical parameters for on-chip manipulation  
Given the flexibility noted previously, and its potential for use in both lab-on-chip systems and in vivo, 
ultrasound has many useful potential capabilities. However, it also has several limitations. The first of these, 
shared with several other manipulation techniques, is the limited contrast between a fluid medium and cells or 
the particles (drug delivery vehicles for example) of interest in drug delivery [7]. In the case of ultrasound, this 
contrast is expressed in terms of the densities and compressibilities of the fluid and the particle, as discussed 
in section 2.1 above. Cells, micelles, and loaded drug delivery vehicles such as liposomes have parameters 
similar to those of water and tissue, limiting the efficiency of the ultrasound intervention. Relatively high 
ultrasound intensities are thus sometimes required to exert sufficient force, making secondary problems more 
likely. These include: acoustic streaming, which increases with increasing ultrasound intensity [20]; the need to 
control excessive heating of the lab-on-chip device through high drive signals applied to the piezoelectric 
source of ultrasound [47] and other materials in the structure; and cavitation [48], which occurs above a 
threshold depending on the level of the impurities in the fluid which act as cavitation nucleation sites and 
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which may be expected to be high in lab-on-chip media. All these problems may affect cell viability [49]. On 
the other hand, gas-filled microbubbles have high ultrasound contrast because of their high compressibility 
[10]. This offers the possibility to label cells, to implement effective manipulation of drug delivery vehicles, and 
to manipulate various functional particles. 
Another fundamental limitation of ultrasound is the difficulty to isolate it to specific regions within a substrate. 
Acoustic absorber materials are available commercially (e.g. Precision Acoustics, Dorchester, UK) but these 
may be difficult to integrate with other lab-on-chip fabrication processes. Ultrasound does not penetrate 
gaseous media effectively, so it may be possible to configure physical gaps in the device to contain 
propagation, but it is likely that ultrasound will propagate within the substrate. Thus, reports of arrays of 
ultrasound-actuated lab-on-chip devices on a common substrate focus on multiwall configurations [50] with 
ultrasound generated in a remote position on the substrate for application in the microfluidic components of a 
device, for example in transversal resonance [35] and SAW devices [38]. 
Acoustic isolation is a complicating factor in the fabrication of ultrasound-actuated lab-on-chip systems and 
the need for a piezoelectric material to generate ultrasound is another one. For SAW devices, the substrate is 
typically made of lithium niobate [51] and for bulk wave resonators, piezoelectric ceramic is used [52]. 
However, both of these are relatively expensive materials so they point towards the possibility to use a 
separate sterile microfluidic component, such as a capillary, to reduce the cost of disposal and replacement for 
each biological sample [30]. It is also possible to integrate piezoelectric materials in thick [53] or thin film [54, 
55] form, or indeed bonded bulk material [56], with other components. Requiring an additional level of 
fabrication sophistication, typically including photolithography [57], this approach may be very useful when 
the number of devices is high and may be a key issue in differentiating acoustic manipulation from optical 
manipulation [58], where integration is still much harder. 
As noted previously, another important issue is temperature. Ultrasound, in its nature as a wave phenomenon, 
involves propagation of local motion of material within the host solid or liquid media. (It does not propagate 
effectively in gas at the frequencies required for lab-on-chip use.) This motion is ultimately dissipated as heat, 
particularly in the solid components of the lab-on-chip system. Ingeniously, this is being harnessed in systems 
in which it is taken into account in the need to maintain the optimum temperature for cells [47]. In that case, it 
simply allows less external heating to be applied. However, care must be taken to avoid local hot-spots which 
may occur near the transducer because of excess heating from the ultrasound generation process or in 
relatively lossy media. For example, the acoustic attenuation (approximately equivalent to heating) in PDMS 
and other plastics is much higher than in glass and silicon [59]. 
Often, if adequate intensity can be achieved without causing damage, the most important parameter in 
ultrasound systems is frequency. Frequency is associated with several other properties of a lab-on-chip 
system, including the force that can be applied for given target moiety dimensions, as discussed in Section 2.1. 
The radiation force equations [12] suggest that, in general, higher frequencies should be used and as 
frequency relates inversely to wavelength [60], which defines the spatial resolution of the manipulation 
process, higher frequencies may also represent an improvement. For example, at frequency f = 1 MHz, the 
wavelength in water (and tissue, blood etc)  ≈ 1.5 mm. A comparison with typical dimensions of cells or drug 
delivery vehicles, of the order of 10 m or less, suggests that a higher frequency is indicated, for example, 
f = 10 MHz,  ≈ 150 m [61]. Indeed, when SAW devices are adopted, in which higher frequencies are as easy 
to achieve as lower ones, frequencies of this order are used [62].   
On the other hand, ultrasound frequency typically determines at least one dimension of the device used to 
generate it, for example thickness of piezoelectric material in bulk wave devices [52]. Thus, higher frequency 
operation almost inevitably complicates fabrication of thickness and transversal resonance devices [63, 64]. It 
also increases attenuation and thus heating, and acoustic streaming (see Section 2.2). The former may be 
beneficial in reducing leakage of ultrasound into unwanted regions in the device, but it is also likely to hinder 
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scale-up. Thus, in general, where high frequency is easy to achieve, in SAW devices, it is used and where it is 
difficult and high resolution is desirable in bulk wave devices, the highest practical frequency is used. 
Nevertheless, there are many situations in which relatively low frequency bulk waves are used, even in 
relatively complicated devices; in this case, they are simply matched to the microfluidic channel dimensions 
[44]. 
3. BIOLOGICAL EFFECTS 
In addition to the acoustic forces which can be generated using ultrasound for the purposes of particle 
manipulation, the management of acoustic forces to generate controlled bio-effects in cells and tissues 
provides an additional important role within on-chip devices; particularly for drug delivery applications. The 
two most important implications of these biological effects can be summarised as sonoporation, the 
generation of porosity in cell membranes using ultrasound and commonly used to enhance particle uptake in 
vivo for drug delivery, and cell viability, the sometimes undesired consequence of compromising cell viability 
as a result of the biological effects generated. These two issues are addressed here.  
 3.1 Cell viability  
While ultrasound is well established as a medical tool for diagnostic imaging, it is also known to be capable of 
damaging tissue through thermal and mechanical effects [49], so if ultrasound is to be widely employed for the 
manipulation of cells it is important that potential effects on the cells themselves are investigated and 
understood.  The frequencies and pressure amplitudes used in cell manipulation are of the same orders as 
those used in diagnostic imaging, and the fact that the bioeffects of imaging have been exhaustively studied 
without evidence of tissue damage suggests that cell damage in manipulation devices due to ultrasound is 
unlikely [65].  However the nature of the ultrasonic environment in a standing wave device is quite different 
from that experienced by cells in tissue during imaging so a thorough evaluation of the response of different 
cell types to such fields is crucial [65].  Studies by Doblhoffdier et al. [66] suggested that there was no 
significant loss in the viability of mammalian cells suspended in a large ultrasonic resonator at operating power 
levels. This conclusion was also reached in a study by Bohm et al. [67] using a similar chamber.  These authors 
noted a significant difference between the response of cells to standing and travelling waves of similar 
frequency and pressure amplitude and a review of the behaviour of cells in such large resonators under 
different operating conditions was provided by  Shirgaonkar et al. [68].   The viability of mammalian cells held 
by ultrasonic forces within a mesh has been shown to be retained [69] and erythrocytes exposed to acoustic 
field strengths high enough to induce mixing showed no significant damage [69]. Hultström et al. [70] 
suspended aggregates of cells in a flowing culture medium within a microfluidic chip and showed that not only 
their viability, but also their ability to proliferate was maintained and the same group demonstrated that cells 
exposed to ultrasound in a multi-well micro-plate for three days retained the potential to proliferate [50]. A 
series of papers by Bazou and co-workers has examined the behaviour of ultrasonically suspended cell 
aggregates [71, 72] and have shown that embryonic stem cells levitated in an ultrasonic field for an hour retain 
pluripotency and their gene expression is unmodified [73]. It should be noted however, that while ultrasound 
at the frequencies and pressures employed in these studies (low MHz regime and  0.08-0.85 MPa) was not 
shown to influence viability or proliferation, other studies have shown that ultrasound is capable of modifying 
cell surfaces through removal of the microvillae normally present on them [74]. 
 
 3.2 Sonoporation in resonant chambers  
While the use of ultrasound-driven microbubbles to enhance the delivery of materials to cells has largely 
dominated the literature, sonoporation in the absence of microbubbles has perhaps remained underexplored. 
Nevertheless, ultrasound alone has also been demonstrated as an effective method of improving cellular 
uptake of genes [75], plasmid [76] and fluorescent probes [77]. In fact a number of studies have demonstrated 
effective delivery using ultrasound alone and indicate that such techniques can be conducted with good cell 
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viability, which in some cases may present an advantage over microbubble techniques which can lead to cell 
death and capillary damage under some operating conditions. 
Lee et al. [75], used ultrasound standing waves in the absence of microbubbles to overcome the low 
transduction efficiency commonly associated with retrovirus delivery to cells in vitro resulting in a four-fold 
improvement in delivery. Erythroleukemia cells arranged in bands using standing waves generated at 1 MHz 
(continuous wave) were exposed to circulating vesicular retroviruses. The small viruses (100 nm) were 
attracted to these bands where the cells acted as nucleating sites, improving the encounter probability 
between cells and delivery material. The effect was enhanced by the size disparity between cells and 
retroviruses, since acoustic radiation force dominates over microstreaming for large particles leading to the 
ability to agglomerate cells, while the reverse is true for smaller ones allowing the circulation of retroviruses 
amongst the cells. The group were able to demonstrate that using this technique uptake was improved over 
Brownian motion alone as it was hypothesised that cells were exposed to the retroviruses before their rapid 
decay.  
The study claimed that the effect of sonoporation could be ruled out from having an effect on improving cell 
delivery because exposure to travelling waves in the absence of standing waves did not improve cellular 
uptake. However, since sonoporation simply means an increase in cell permeability due to sound and the 
impact of microstreaming, which other studies have demonstrated may generate cell permeability [78], has 
not been established in this study this claim may not be entirely accurate. Finally, the authors point out that 
use of ultrasound standing waves leads to high rates of cell viability and improves the suitability of ultrasound 
to enhance delivery of materials to cell suspensions and not just plated cell lines, making it particularly 
applicable to large scale applications. 
Rodamporn et al.[76] similarly found transfection of HeLa cells was improved through exposure to ultrasound 
standing waves, while maintaining cell viability in excess of 78%. In this case cells were transfected with a 
plasmid encoding green fluorescent protein using a sonoporation frequency (980 KHz, 0-19.5 MPa) determined 
through impedance analysis of the fluid layer contained within a custom designed chamber, incorporating fluid 
inlet and outlets and a piezoceramic active element and matching layer operating around a glass chamber. In 
this case it was hypothesised that successful delivery of material to cells occurred as a result of sonoporation 
generated by the viscous shearing occurring as a result of microstreaming.  
A further study employing the techniques presented by Rodamporn et al. found two population effects when 
considering the porosity developed in cells exposed to standing waves at 2.27 MHz over a pressure range from 
0.11-1.39 MPa [77]. The first population of cells showed an exponential decay in porosity over time following 
the initial exposure. It was theorised that this could have occurred as a result of the initial acoustic exposure 
used to initiate transport to the pressure antinode, since it has been theorised that sonoporation may result 
from intramembraneous cavitation [79]. The second population of cells showed sustained poration over a 
longer period. In this case the authors hypothesise that poration only occurred following exposure of these 
cells to a critical number of oscillatory strain cycles. In summary the authors believe poration may result from a 
combination of these effects as evidenced by the two distinct populations and may be further enhanced by the 
fluid shear stresses generated by non-inertial streaming. 
 
 
4. EXAMPLE APPLICATIONS 
 
 4.1 Overview  
Ultrasonic manipulation has been investigated in a variety of microfluidic applications.  Two recent review 
papers distinguish between applications that involve the trapping of particles and cells [13] and those that use 
radiation forces within continuous flow microsystems [2].  Trapping of particles can be used to enhance 
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bioassays [80], by increasing bead interactions in agglutination assays [81], or by trapping particles on 
functionalised surfaces [14].  Cells can be trapped directly in order to concentrate them for forensic analysis 
[36] and it is possible to enhance the trapping of small bacteria and nanoparticles by introducing larger seed 
particles into the ultrasonic field [82].  
Success in ultrasonic manipulation at the single cell level has also been demonstrated [83]. A rather different 
approach has enabled single cells to be trapped and manipulated by very high frequency focused ultrasound.  
While fabrication challenges are commonly cited as the limiting factor in using single element focused 
ultrasound devices to manipulate cells, recent progress in piezoelectric materials generation and handling 
indicate the situation may be changing. Lee et al., [84] recently demonstrated the manipulation of a single 10 
µm leukaemia cell using a focused transducer operating at 200 MHz. The device consisted of a 6 µm thick layer 
of zinc oxide sputtered on the back surface of a sapphire buffer rod, formed at the opposing surface to 
generate a spherical focusing lens. Acoustic coupling into water was improved through addition of a glass 
matching layer. The resulting device had a beam full width at half maximum of 9.5 µm at its focus, 0.5 mm 
from the front face of the focusing lens. 
Lenshoff et al. [2] describe continuous flow systems for effecting concentration, filtration, separation, 
characterisation, medium-exchange, and the switching of particles between streams for applications such as 
fluorescence-activated cell sorting.  These applications are described extensively in [2] and other recent 
reviews [31, 43] so the remainder of this section will concentrate on the applications relevant to tissue 
engineering and drug-cell interactions. 
 
 4.2 Assembly and Tissue Engineering  
The ability of ultrasonic fields to control the position of cells suggests that it should be possible to use the 
technology to enhance the formation of cell aggregates for in vitro tissue engineering, prior to implantation for 
example. Further, for certain cell types there is evidence that the microenvironment provided by ultrasonic 
excitation can modify and enhance the production of the cells’ extra cellular matrix [85, 86].  A detailed study 
of the response of chondrocytes to culture within polymer scaffolds under ultrasonic excitation [87] observed 
positive changes in viability, proliferation, and gene expression, and modified expression of a large number of 
proteins, in comparison with control samples in the absence of ultrasonic excitation.  One relevant application 
of ultrasound is for enhancing the seeding of tissue engineering scaffolds. Surface acoustic waves can be used 
to generate acoustic streaming within a cell-containing droplet, to drive that droplet to a porous scaffold, and 
then use the acoustically induced flow to improve the penetration of the cells within the scaffold [88, 89]. 
Working without scaffolds, Liu et al. [90] formed aggregates of a hepatocyte cell line within an ultrasonic trap, 
using the ultrasound to accelerate the aggregate formation and to modify their geometry during the initial 30 
minutes of their formation. The cells were then maintained in culture in the absence of ultrasound for up to 
three weeks and shown to have similar functional characteristics to hepatocyte spheroids prepared using 
gyrotation culture techniques.  The same group subsequently modified the technique so as to culture the cells 
within alginate beads following ultrasonically assisted formation [91] and further demonstrated the ultrasonic 
assembly of multiple cell aggregates simultaneously within different geometry resonators [92]. More recently, 
Bazou et al. [15] extended the techniques for the controlled assembly of two and three dimensional 
suspended cell aggregates by demonstrating that changing the characteristics of a pulsed standing wave could 
be used to modify the geometry of the aggregates. 
Garvin et al. have used ultrasonic fields to pattern cells within collagen hydrogels [86] and suggest that the 
ultrasound-induced cell patterning itself has a significant influence on the structure of the extracellular matrix. 
They later used this technique to organise endothelial cells so as to form a vascular-like bed within the matrix 
[93].  Mazzoccoli et al. also worked in hydrogels to form concentric cylindrical arrangements of a breast cancer 
cell line (MDA-MB231) [94].  
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An alternative approach relies on the potential of multiple pairs of transducers to create one and two 
dimensional patterns of particles or cells.  Ding et al. [95] arranged lines of stromal cells and hepatocytes at 
controlled positions on a substrate using standing surface acoustic waves. Bernassau et al. [96] used bulk 
acoustic waves generated by a heptagonal arrangement of transducers to act as an ultrasonic stencil, to 
deposit predefined patterns of cells on a glass cover slip and also demonstrated the ability to place different 
batches of cells at predefined relative positions. The group has also demonstrated the ability to pattern 
functionalised microspheres and microbubbles with the same technology [97]. Finally, the use of ultrasound 
transducer arrays holds significant promise for adaptive systems in which cell positions are monitored, 
allowing the electronic signals driving the array to be adjusted as the cell cultures develop. This is illustrated in 
simple form by an adaptation of the configuration shown in Fig. 2 to include a one-dimensional transducer 
array as shown in Fig. 3. 
 
Figure 3. An extension of the arrangement in Fig. 2 in which the single transducer beneath the cells is replaced by a 
transducer array under electronic control [44]. This allows the device to adapt its behaviour in the lateral direction 
according to changes in the cell culture. For example, two aggregates of cells could be grown separately under levitation 
then brought together at an appropriate stage. 
 
4.3 Study of drug-cell interaction 
Ultrasound can be used in lab-on-chip configurations to enhance the application of drugs to both cell 
ensembles and single cells, unlike some alternative techniques such as optical tweezing [98] which are 
appropriate mainly for single cells. In addition, its realisation with piezoelectric devices [30] allows relatively 
straightforward integration with other lab-on-chip components, principally those used to fabricate microfluidic 
channels and systems. Amongst the most exciting work at present is in single cell manipulation, and it is on this 
that we concentrate here. Despite the significant advances in lab-on-chip technologies and their application to 
devices for drug delivery systems, the goal of single cell manipulation and the ability to perform automated 
tasks on single cells remains a challenge. The application of ultrasound, and the several technologies embodied 
by ultrasound, to this rapidly developing field presents several important opportunities in the pursuit of single-
cell level manipulation within lab-on-chip devices. 
The control, processing and analysis of single cells are essential for the continuing development of on-chip 
drug delivery systems. The ability to operate on single cells rather than cell populations limits dilution of the 
cell content, improving process efficiency, control and sensitivity. It allows the processing and analysis of 
several samples simultaneously to produce large volumes of detailed information on cellular responses, and 
enables improved dosage and experimental control [99]. Effective trapping, isolation and sorting of single cells 
will enable targeted delivery for gene therapy applications, detailed study of drug-cell interactions in drug 
delivery and development, cell selection for IVF, and improved sensitivity as required to address several 
emerging diagnostic applications [100]. These requirements are emphasised further by improved community-
wide appreciation of the issues relating to cell heterogeneity and the need to investigate how the resulting 
stochastic and transient variations in cellular response can impact drug development and treatment efficiency. 
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Until recently, two approaches could be considered to dominate contactless single cell/particle manipulation, 
negative dielectrophoresis (electrical forces) and laser tweezing (optical forces). Each offers high spatial 
resolution and accuracy but also requires complicated and costly equipment. Ultrasonic cell manipulation may 
offer the potential to address many of the challenges outlined above, particularly when considered alongside 
microfluidic and microplate manipulation. Ultrasound holds benefits over competing technologies since it can 
be achieved at relatively low cost without significant equipment investment. It is highly suited to incorporation 
within optical microscopy, and employs relatively low power densities for improved cell viability and 
opportunities for longer term cell study [70]. 
There are many examples of inclusion within microdevices with the aim of particle manipulation for on-chip 
technologies. Motivated by the time-consuming nature of generating statistically significant data for cell 
interactions within in vitro suspensions, Forslund et al demonstrated that ultrasound can be used to induce 
and synchronise cell-cell contact between natural killer (NK) and target cells in multiwall plates [101]. The 
microchip platform developed was compatible with microscopy analysis and supported coordination of 
multiple experiments simultaneously. 
Enhancement of ultrasound effects using gas microbubbles 
Particular success in ultrasound mediated drug delivery has been achieved with the use of gas microbubbles 
[102-105]. The disparity in acoustic properties between the gas and surrounding media present several 
opportunities to augment the effects of ultrasound alone. Microbubbles, consisting of a high molecular weight 
gas core stabilised by a lipid, protein or polymer shell, were first produced commercially as ultrasound contrast 
agents (USCAs) in the 1980s [106]. Their ability to act as foci for the release of ultrasound energy has long been 
established and has led to their exploitation for therapeutic applications [102, 107, 108]. The huge interest 
generated by the technique supports a vibrant field of research and significant literature concerning 
characterisation now exists [109-111].  
Upon excitation by an acoustic wave, microbubbles undergo rapid expansion and contraction [112]. This can 
be used to generate stable cavitation and localised shear stresses at low acoustic intensities [113]. As the 
acoustic intensity increases the microbubble shell can no longer support the increasing radial excursion leading 
to fragmentation. At high acoustic intensities, microbubbles can be driven to inertial cavitation resulting in 
catastrophic collapse and gas jetting.  Their strongly resonant behaviour allows the extent of the effects to be 
manipulated through ultrasound frequency selection and their non-linear response, particularly at higher 
acoustic intensities, supports the generation of acoustic radiation forces. Fig. 4 shows an example of albumin-
coated microbubble oscillation under acoustic excitation leading to shell disruption and gas jetting.  
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Figure 4. Change in microbubble diameter during ultrasound excitation (0.5 MHz carrier signal windowed using a 
Gaussian function with a full width half maximum equivalent to 12 cycles of the carrier and peak negative pressure of 
approximately 100 kPa) (a) and a series of sample images used to produce the trace, illustrating the microbubble at its (i) 
initial, (ii) maximum and (iii) minimum diameter, (iv) evidence of gas jetting and (v) final diameter.  The high speed 
images were acquired at a camera frame rate of 2 Mfps. (Reproduced from [114] with permission from Elsevier). 
 
Microbubbles can be used to generate transient porosity in cells and vasculature at diagnostic ultrasound 
intensities to facilitate drug and gene delivery both in vitro and in vivo [115, 116]. It is generally considered 
that both stable and inertial cavitation lead to the generation of bio-effects which either mechanically rupture 
the phospholipid structure of the cell membrane or disrupt/invoke cell-regulated pathways. In each case, it is 
accepted that the resulting pores are resealed by the cell within a few minutes; thus this approach is 
considered to be less destructive at a cellular level than alternative methods such as electroporation, laser 
irradiation and microinjection for cellular transfection [102].  
As microbubbles can be functionalised with targeting ligands to improve their affinity to particular tissues or 
disease locations [117] they can transport drugs or genes for ultrasound mediated release at a particular 
location [103, 118, 119]. In micro devices, microbubbles have been used for selective trapping based on 
particle size and density before further processing (mixing and aggregation) [120]. The layout of the device 
developed for this follows the basic principle illustrated in Figure 2.  
A significant limitation of microbubbles in vivo is their rapid clearance from the blood pool as they are either 
destroyed by ultrasound, dissolve due to local changes in the content and gradient of dissolved blood-gases, 
are mechanically disrupted as they pass through the cardiac and pulmonary systems or are sequestered by the 
reticuloendothelial system. In microfluidic devices, the limitations are likely to involve high surface tension, 
shear stresses, rapid changes of pressure or exposure to high pressure, and friction generated heating and 
evaporation of the small volumes of water involved; these remain to be overcome before microbubble 
utilisation in micro devices can be considered optimum.  
Finally, in addition to the employment of microbubbles in on-chip devices, novel techniques for microbubble 
fabrication [121] have been adapted to miniaturised platforms [122, 123] enabling lab-on-chip microbubble 
fabrication for drug delivery applications and the control of microbubble diameter to yield monodisperse 
microbubble suspensions. The techniques have also been demonstrated for the fabrication of liposome 
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functionalised microbubbles [122] and in some cases the intention is that this sort of technology could be used 
to deliver microbubbles from an intrasvascular catheter directly to the treatment location [123]. 
A key driver in many drug delivery investigations is to determine the mechanisms responsible for porosity 
generation in order to improve delivery efficiencies when such techniques are applied in vivo. In addition to 
the well-recognised involvement of cavitation, recent studies have demonstrated an association between 
oscillating microbubbles and some physiological or cell regulated mechanisms of porosity, or, for example, 
endocytosis [124, 125].  
 
Drug Discovery 
A significant potential application of ultrasound for particle and cell manipulation is within the arena of drug 
discovery, where exhaustive in vitro investigation of drug – cell interactions is an essential step in 
understanding and developing new therapeutic agents. The additional control offered by incorporating 
ultrasound manipulation techniques within existing experimental protocols offers significant opportunities to 
accelerate early stage drug development. The manipulation techniques outlined above provide the means to 
coordinate delivery of materials across multiwell plates [50] for parallel investigation and aggregate drugs, 
cells or combinations of each to control and initiate interactions at specific time points. The results could 
improve experimental throughput by orders of magnitude reducing development times and perhaps enabling 
more comprehensive investigations. It is also likely that such powerful in vitro development tools could lead to 
reduced in vivo experimental requirements, which can be unpopular and expensive. Indeed, several 
investigators have highlighted the relevance of their approaches to drug discovery [76, 77] and Fig. 5 shows 
the approach taken by Carugo et al. [77] to enhance drug uptake in the absence of contrast agent.  
  
Figure 5. Schematic representation of sonoporation as described by Carugo et al. [77]. (a) In the absence of ultrasound 
the cell membrane is permeable only to small molecules (top-left). Under ultrasonic excitation (top right) 
transmembrane transfer of molecules was facilitated (bottom). (b) Sonoporation took place within an ultrasonic standing 
wave excited within a capillary, which moved cells to the acoustic pressure node. Reprinted with permission from Carugo 
et al. [77]. Copyright 2011, American Institute of Physics. 
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Potential of ultrasound for drug delivery 
The influence of ultrasound on both cells and carriers for drugs, linked with its established ability to penetrate 
into tissue without any incisions, has led to significant research in ultrasound-mediated drug delivery [126]. In 
turn this suggests two directions for on-chip ultrasound-assisted work, first, to take advantage of the same 
capabilities that make ultrasound attractive for drug delivery and, second, to minimise the barriers in 
translation from research and development in vitro to application in vivo. 
 
Use of ultrasound to deliver materials across the normally impermeable cell membrane is well documented 
[99, 127]. In these applications it is thought that acoustic cavitation is the dominant mechanism, where 
dissolved gases are caused to nucleate and then rapidly collapse at high peak negative acoustic intensities, 
releasing energy and free radicals and causing jetting [128]. As mentioned above, standing waves have also 
been demonstrated to be effective in enhancing cellular uptake [76, 78, 129] where the mechanism is thought 
to be microstreaming, resulting in shear stresses on the cell membrane leading to porosity. Recent studies 
have suggested that standing wave generation may be as important as cavitation in effective ultrasound 
mediated drug delivery [78] and that it can have a protective effect, improving cell viability, due to the absence 
of a greatly fluctuating pressure [130]. 
Ultrasound can also affect drug carriers and thus offers two routes to drug delivery, the first by increasing the 
permeability of cells so that the drug-carrier complex can enter the cells for drug release there, with chemical / 
biological processes, and the second by enhancing the release of the drug from its carrier in proximity to the 
target cells through heating or mechanical disruption, potentially with cavitation. For ultrasound-mediated 
delivery, carriers can take the form of complex molecules [131], micelles and liposomes [132], and 
microbubbles [133]. Molecular carriers, micelles and liposomes are particularly amenable to the first 
mechanism but microbubbles are too big. However, as microbubbles loaded with drugs are closely equivalent 
to conventional ultrasound contrast agents, mechanisms are available to break them down into pieces small 
enough to penetrate biological systems including vascular walls and cells [105]. 
It is thus possible to foresee a translational pathway in which ultrasound-mediated drug delivery is 
investigated first in vitro with lab-on-chip approaches based on existing and future acoustic manipulation 
techniques [131], followed by a conventional in vivo pathway through small animals to human trials based on 
established and future ultrasound beam forming algorithms, potentially taking advantage of advanced 
techniques adapted from optics, such as the use of Bessel beams [134]. Equipment specifically for this 
translation pathway is already under development, such as the high throughput sonicator system shown in 
Fig. 6 and reported in detail elsewhere [135]. 
 
Figure 6. A system designed to allow high throughput evaluation of the effects of ultrasound for drug delivery. The 
standard 96-well plate is passed over several ultrasound transducers under computer control, allow selective sonication 
of the contents of particular wells. 
 
5. CONCLUSIONS AND OUTLOOK FOR THE FUTURE 
Ultrasound offers a means of developing controlled, non-contact forces capable of extending the functionality 
of lab-on-chip devices.  In many cases ultrasound offers advantages over current methods used on-chip. For 
example, the use of acoustic tweezers for particle manipulation and sorting rather than optical tweezers offers 
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advantages in cost, space requirements, and the use of regulated equipment (high intensity lasers), while 
exerting minimal impact on cell viability and proliferation [65].  There is documented evidence that standing 
waves can generate cellular stress [78] and further work is required to understand the implications of this. 
Ultrasound can be used with microbubbles to extend functionality to include mixing [120], mechanical 
excitation of cells [113], drug delivery [102], and spatial and temporal control of drug release [103, 119]. 
Ultrasound may be considered to be most effective as a means of manipulating groups of cells or particles. 
This provides significant potential for building and investigating tissue constructs on-chip and provides a useful 
tool in exploring cell-cell interaction [101]. Devices with more dexterous manipulation abilities [46, 97] should 
be able to extend this capability, for example by allowing different cell types to be brought together in a highly 
controlled environment.  There is also potential to use acoustic manipulation in conjunction with other force 
fields such as optical tweezers or dielectrophoresis that have a more local scale of action [136], taking 
advantage of the strengths of both approaches. In most cases further work is required before ultrasound alone 
can be used effectively to manipulate single cells or other micron-scale particles, however, this may well be a 
realistic possibility in future devices [84].   
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